JW Holdings Signs Technology Export Deal for Total Nutritional Infusion Solution with Chinese Pharmaceutical Company Worth 44 Billion KRW

[Asia Economy Reporter Cho Hyun-ui] JW Holdings announced on the 26th that it has signed a technology export and supply contract for the comprehensive nutritional infusion product 'Winnerf' with Shandong Luoxin Pharmaceutical Group, a subsidiary of China's Luoxin Pharmaceutical Group.

Through this contract, JW Holdings will sequentially receive a total of $39 million (approximately 44 billion KRW), including a non-refundable advance payment of $5 million (about 5.6 billion KRW) and up to $34 million (about 38.4 billion KRW) in milestones based on development, approval, and sales. After approval, JW Holdings will also receive royalties based on Shandong Luoxin's net sales within China.

Shandong Luoxin has acquired exclusive rights for the development and commercialization of Winnerf in the Chinese, Hong Kong, and Macau markets through this contract. Details related to the finished product supply contract remain confidential by mutual agreement. JW Life Science is responsible for the production and supply of Winnerf.

Winnerf is a third-generation comprehensive nutritional infusion composed of four lipid components?refined fish oil (20%), refined soybean oil (30%), olive oil (25%), and MCT (25%)?as well as glucose and amino acids. Compared to existing products, it contains a higher amount of refined fish oil, resulting in increased omega-3 and omega-6 fatty acids that enhance immunity and promote recovery.

Winnerf, launched domestically in 2013, recorded domestic sales of 55.7 billion KRW last year.

It has also entered the European market, becoming the first Asian pharmaceutical company to do so. According to JW Holdings, JW Group is the only domestic company to have entered the global infusion market and the first among Asian pharmaceutical companies.

Han Sung-kwon, CEO of JW Holdings, stated, "JW is gaining recognition in the global high value-added comprehensive nutritional infusion market through bold investment and innovative technology development," adding, "We plan to further expand Winnerf's global market opportunities through this technology export."